A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer (opens in a new tab)
Active, not recruiting
$33 in research paymentsCarcinoma, Non-Small-Cell LungCarcinoma, BronchogenicAbemaciclibErlotinib
Dr. Stephan D. Kendall, MD
NPI1033293196PAC ID3173567708
- Medicare services, 2024
- 31,606
- Medicare patients, 2024
- 315
- Part D claims, 2024
- 769
- Clinical trials
- 5
- MIPS score, 2024
- 87
- Practice address
- 1121 E 3900 S, Salt Lake City, UT 84124
- Practice phone
- Call (801) 269-0231
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Utah Cancer Specialists
Salt Lake City, Utah
Find Dr. Kendall's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Stephan D. Kendall is a medical oncologist in Salt Lake City, Utah
Dr. Kendall practices at Utah Cancer Specialists in Salt Lake City, Utah.
Dr. Kendall's NPI, 1033293196, was assigned on October 25, 2006. Dr. Kendall graduated from Albany Medical College of Union University in 1999. Dr. Kendall holds Utah license 8654924-1205.
NPI and contact details
- NPI
- 1033293196NPI Registry (opens in a new tab)
- Medicare PAC ID
- 3173567708
- NPI enumeration date
- October 25, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (801) 269-0231
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 53
- Medical school graduation
- 1999
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Stephan D. Kendall practices at Utah Cancer Specialists in Salt Lake City, Utah
Dr. Kendall's primary practice is Utah Cancer Specialists, at 1121 E 3900 S, Salt Lake City, UT 84124 in Salt Lake County. The practice phone is (801) 269-0231.
- Utah Cancer Specialists1121 E 3900 S, Salt Lake City, UT 84124 · Salt Lake CountyPhone(801) 269-0231
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Stephan D. Kendall is affiliated with 7 sites of care and 2 medical groups
Dr. Kendall's primary practice is Utah Cancer Specialists in Salt Lake City, Utah. Dr. Kendall is also affiliated with St. Mark's Hospital. The medical group on file is Utah Cancer Specialists. Dmand AI also links Dr. Kendall to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.
Utah Cancer SpecialistsPrimary
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Stephan D. Kendall's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kendall practices, 6 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Utah Cancer Specialists | Available with a free account |
| +6 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Kendall practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Stephan D. Kendall is one of 39 medical oncologists in Utah
Medical oncology is Dr. Kendall's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Kendall's licenses on file in 2 states: Utah and North Carolina.
Specialties and state licenses
- Medical oncology, UtahPrimary
- Hematology and oncology, North Carolina
Medical oncologists near Dr. Kendall
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Stephan D. Kendall billed Medicare for 31,606 services in 2024
CMS data shows 31,606 Medicare services from Dr. Kendall across 41 procedure codes in 2024, for 315 Medicare patients. Medicare paid $156,553 for them. Every service was in an office.
Medicare services, 202431,606
Medicare patients315
Paid by Medicare$156,553
Procedure codes41
Dr. Kendall's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 22,1182024: 26,00318%
- Other services
- 2023: 3,1552024: 2,77312%
- Lab and pathology
- 2023: 1,4472024: 1,5175%
- Tests and treatments
- 2023: 5052024: 69137%
- Office and hospital visits
- 2023: 5012024: 5459%
- Imaging
- 2023: 702024: 7710%
Dr. Kendall compared with the Utah median for medical oncologists, 2024
- Dr. Kendall
- Utah median
- Medicare services
- 31,606vs 64449.1 times
- Medicare patients
- 315vs 1382.3 times
- Part D claims
- 537vs 32963% above
Medians across 39 medical oncologists in Utah with Dmand AI profiles that report each measure.
Dr. Kendall's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Kendall?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Kendall and other medical oncologists in Utah.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Stephan D. Kendall treated 315 Medicare patients in 2024, average age 75
CMS counts 315 Medicare patients who saw Dr. Kendall in 2024. The largest group is 65 to 74, with 138 patients. 70% of them have high blood pressure, and 60% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Kendall's median patient age at 67, with 60% women.
Medicare patients, 2024315
Average age75
Average risk score1.95
Also on Medicaid7%
Dr. Kendall's Medicare patients by age, 2024
Dr. Kendall's Medicare patients by sex, 2024
- Women17455%
- Men14145%
Chronic conditions among Dr. Kendall's Medicare patients, 2024
- High blood pressure70%
- High cholesterol60%
- Arthritis43%
- Cancer42%
- Chronic kidney disease33%
- Diabetes32%
- Mood disorders28%
- Depression27%
Share of Medicare patients with each condition. A patient can have several.
Dr. Kendall's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 67
Patient panel by sex, all payers
- Women60%
- Men39%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Stephan D. Kendall wrote 769 Medicare Part D claims in 2024
In 2024, Dr. Kendall wrote 769 Medicare Part D claims for 147 patients. 72% of them were for generic drugs. CMS names the drug for 537 of them, across 20 drugs with 11 or more claims each, at $2,601,287 in total drug cost. In 2023, CMS named 460 claims across 19 drugs.
Part D claims, 2024769
Drugs named by CMS20
Total drug cost$2.6M
Part D patients147
Dr. Kendall's Part D claims by kind of drug, 2024
- Generic553 claims72%
- Brand-name216 claims28%
Dr. Kendall's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Kendall's Part D claims, 2024
- Opioids4%31 of 769 claims
- Antibiotics5%42 of 769 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 4602024: 53717%
Drugs named by CMS: 20 in 2024, 19 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Stephan D. Kendall scored 87 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Kendall for performance year 2024, reported as part of a group. Dr. Kendall accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Kendall's MIPS scores, performance year 2024
- 87of 100Final score
- 77.3of 100Quality
- 90of 100Promoting Interoperability
- 40of 100Improvement Activities
- 78of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find medical oncologists like Dr. Kendall by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Stephan D. Kendall has worked on 5 clinical trials
Dmand AI links Dr. Kendall to 5 clinical trials. 4 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Carcinoma, Non-Small-Cell Lung. Eli Lilly and Company sponsors the most, 5. Open Payments lists research payments to Dr. Kendall that name 5 trials.
Conditions in Dr. Kendall's trials
- Breast Neoplasms
- Breast Diseases
- Carcinoma, Non-Small-Cell Lung
- Histiocytoma
- Neoplasm Metastasis
Investigators on the most trials with Dr. Kendall
- Ronald P. Harris, DO3 shared trials
- Petros George Nikolinakos, MD3 shared trials
- Meghna S. Trivedi, MD3 shared trials
Recent clinical trials with Dr. Kendall
$4,046 in research paymentsHistiocytomaHistiocytoma, Malignant FibrousDoxorubicinOlaratumab
Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer (opens in a new tab)
Active, not recruiting
$2,899 in research paymentsBreast NeoplasmsBreast DiseasesAbemaciclibStandard Adjuvant Endocrine Therapy
A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer (opens in a new tab)
Active, not recruiting
$36 in research paymentsNeoplasm MetastasisNeoplastic ProcessesAbemaciclibImlunestrantExemestane
A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer (opens in a new tab)
Active, not recruiting
$640 in research paymentsBreast NeoplasmsBreast DiseasesAbemaciclibFulvestrant
Sources: Open Payments (CMS), 2025 data, released July 7, 2026; ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
Dr. Stephan D. Kendall received $5,858 in industry payments from 2016 to 2025
CMS Open Payments shows 287 general payments to Dr. Kendall from 46 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Bristol-Myers Squibb Company paid the most, $650. It also lists 8 research payments totaling $7,654 from 2016 to 2022, naming 5 clinical trials.
General payments to Dr. Kendall by program year, 2016 to 2025
General payments to Dr. Kendall by kind, 2016 to 2025
$5.9Kin total
- Food and beverage$5,42993%
- Education$4297%
Companies that paid Dr. Kendall the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Stephan D. Kendall graduated from Albany Medical College of Union University
Dr. Kendall graduated from Albany Medical College of Union University in 1999.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Stephan D. Kendall's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Clinical trials and co-investigators | ClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Stephan D. Kendall
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Stephan D. Kendall's NPI number?
Dr. Stephan D. Kendall's NPI number is 1033293196. It was assigned on October 25, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Stephan D. Kendall?
Dr. Stephan D. Kendall is a medical oncologist in Salt Lake City, Utah. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Stephan D. Kendall practice?
Dr. Kendall practices at 1121 E 3900 S, Salt Lake City, UT 84124. Dr. Kendall's primary practice is Utah Cancer Specialists in Salt Lake City, Utah. Dmand AI also links Dr. Kendall to 3 hospitals, 2 group practices and clinics and 1 medical group.
What is Dr. Stephan D. Kendall's office phone number?
The practice phone on file for Dr. Kendall is (801) 269-0231.
What is Dr. Stephan D. Kendall's medical license number?
Dr. Kendall holds Utah license 8654924-1205, one of the licenses on file in 2 states.
Which states has Dr. Stephan D. Kendall been licensed in?
Dmand AI has state licenses on file for Dr. Kendall in Utah and North Carolina.
Which hospitals is Dr. Stephan D. Kendall affiliated with?
Dr. Kendall is affiliated with St. Mark's Hospital. Dmand AI links Dr. Kendall to 3 more hospitals.
What medical group is Dr. Stephan D. Kendall part of?
Dr. Kendall is linked to Utah Cancer Specialists. Dmand AI links Dr. Kendall to 1 more medical group.
Does Dr. Stephan D. Kendall accept Medicare?
Yes. CMS data shows Dr. Kendall billed Medicare for 31,606 services in 2024, and Dr. Kendall accepts Medicare assignment.
What is Dr. Stephan D. Kendall's MIPS score?
Dr. Kendall's MIPS final score for performance year 2024 is 87 out of 100, reported as part of a group.
Show 7 more questionsShow fewer questions
How many Medicare patients does Dr. Stephan D. Kendall see?
CMS counts 315 Medicare patients who saw Dr. Kendall in 2024, with an average age of 75.
What services does Dr. Stephan D. Kendall bill to Medicare?
In 2024, Dr. Kendall's most billed Medicare services were injected or infused drug (J1439), injected or infused drug (J0185) and injected or infused drug (J1627).
Where did Dr. Stephan D. Kendall go to medical school?
Dr. Kendall graduated from Albany Medical College of Union University in 1999.
What drugs does Dr. Stephan D. Kendall prescribe most?
In 2024 Medicare Part D data, Dr. Kendall's most prescribed drugs by claims were Hydroxyurea, Anastrozole and Brukinsa.
Has Dr. Stephan D. Kendall received payments from drug or device companies?
CMS Open Payments shows $5,858 in general payments to Dr. Kendall from 46 companies from 2016 to 2025. The largest total came from Bristol-Myers Squibb Company.
How long has Dr. Stephan D. Kendall been practicing?
Dr. Kendall graduated from medical school in 1999, 27 years ago.
Does Dr. Stephan D. Kendall do research?
Dr. Kendall has worked on 5 clinical trials.
Selling to medical oncology practices?
See medical oncologists in Utah by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card